Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|ST1926-NP||ST1926-NP is a synthetic adamantyl retinoid stabilized as polymer nanoparticles, which may lead to reduced cell proliferation and a decrease in tumor burden (PMID: 28619754).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||acute myeloid leukemia||not applicable||ST1926-NP||Preclinical - Cell line xenograft||Actionable||In a preclinical study, ST1926-NP treatment resulted in reduced cell proliferation in acute myeloid leukemia (AML) cells in culture, and decreased tumor burden and improved survival in AML cell line xenograft models (PMID: 28619754).||28619754|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|